0
Article ? AI-assigned paper type based on the abstract. Classification may not be perfect — flag errors using the feedback button. Tier 2 ? Original research — experimental, observational, or case-control study. Direct primary evidence. Sign in to save

A Shift from Reactive to Proactive Medicine: A Conceptual Framework for Autonomous Cellular Homeostasis (ACH)

Zenodo (CERN European Organization for Nuclear Research) 2026
Nkechi Chidi Okonji

Summary

Scientists are proposing a futuristic idea called Autonomous Cellular Homeostasis (ACH): tiny engineered cell systems, built from a patient's own stem cells, that could constantly monitor the body for early warning signs of trouble—like damage from microplastics or chemical exposure—and fix problems before they turn into diseases like cancer. This is a theoretical concept, not a real treatment yet, but it points to where preventive medicine might be headed: catching cellular damage early instead of waiting until you're already sick. It's worth knowing about, but major scientific, safety, and ethical hurdles stand between this

Models

Modern medicine remains fundamentally reactive. Significant global investment is directed towards oncology, chronic disease management, and pharmaceutical intervention, yet treatment typically begins only after substantial cellular or tissue dysfunction has already occurred. Simultaneously, emerging environmental pressures - including aerosolised chemical exposure from vaping products, microplastic accumulation, and evolving pathogenic threats, continue to challenge conventional therapeutic timelines. This paper proposes a conceptual framework termed Autonomous Cellular Homeostasis (ACH), a proactive therapeutic architecture designed to detect and mitigate early molecular dysfunction before overt disease manifestation. ACH combines patient-derived induced pluripotent stem cells (iPSCs), synthetic gene circuits, engineered receptor systems, and CRISPR-based transcriptional regulators to create localised theranostic cellular networks capable of continuous environmental sensing and adaptive response. Rather than functioning as a conventional post-diagnostic therapy, ACH is theorised as a closed-loop biological maintenance system that continuously monitors tissue microenvironments, interprets pathological stress signals, and modulates endogenous repair pathways in real time. While highly speculative and subject to major translational, ethical, and biosafety limitations, the framework highlights a potential long-term direction for preventive synthetic medicine.

Share this paper